FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886804753> ?p ?o ?g. }

• W2886804753 endingPage "574" @default.
• W2886804753 startingPage "565" @default.
• W2886804753 abstract "OBJECTIVE: To estimate provision of moderately and highly effective reversible contraceptives to women with intellectual and developmental disabilities. METHODS: We used data from the Massachusetts All-Payer Claims Database to identify women aged 15–44 years with and without intellectual and developmental disabilities who were continuously enrolled in a private commercial insurance plan, Medicaid, or Medicare in 2012. We calculated the percentage of women aged 15–44 years who were not medically or surgically sterile and were provided 1) highly effective, long-acting reversible contraception (LARC, the intrauterine device or subdermal implant); or 2) prescriptions for moderately effective methods (pill, patch, ring, shot, or diaphragm). Logistic regression models estimated the odds of LARC and moderately effective method provision by disability status, adjusted for age, income, and Medicaid receipt. RESULTS: Among 915,561 women who were not medically or surgically sterile, 13,059 women (1.4%) had at least one intellectual and developmental disability. Women with intellectual and developmental disabilities were less likely to be provided LARC (2.1% vs 4.2%, P <.001, adjusted odds ratio [OR] 0.43, 95% CI 0.38–0.48, P <.001) and moderately effective methods (21.1% vs 29.9%, P <.001, adjusted OR 0.68, 95% CI 0.65–0.71, P <.001) than women without intellectual and developmental disabilities. The one exception was the progestin shot, which was provided more often to women with intellectual and developmental disabilities than women without these disabilities (14.7% vs 4.3%, P <.001). Among a subset of women who only received moderately effective methods or LARC (n=310,344), women with intellectual and developmental disability had lower odds of receiving LARC than moderately effective methods (adjusted OR 0.59, 95% CI 0.52–0.67). CONCLUSION: The study findings raise concerns that the provision of LARC and moderately effective methods differs based on the presence of intellectual and developmental disabilities. Greater understanding is needed regarding factors that underlie lower provision of LARC in comparison with moderately effective methods, especially the progestin shot, among women with intellectual and developmental disabilities." @default.
• W2886804753 created "2018-08-22" @default.
• W2886804753 creator A5008356734 @default.
• W2886804753 creator A5023105695 @default.
• W2886804753 creator A5029198271 @default.
• W2886804753 creator A5042320425 @default.
• W2886804753 creator A5091136317 @default.
• W2886804753 date "2018-09-01" @default.
• W2886804753 modified "2023-10-15" @default.
• W2886804753 title "Provision of Moderately and Highly Effective Reversible Contraception to Insured Women With Intellectual and Developmental Disabilities" @default.
• W2886804753 cites W1684134440 @default.
• W2886804753 cites W1919741428 @default.
• W2886804753 cites W1984965721 @default.
• W2886804753 cites W1995860584 @default.
• W2886804753 cites W1997608789 @default.
• W2886804753 cites W2018344303 @default.
• W2886804753 cites W2026076766 @default.
• W2886804753 cites W2026267768 @default.
• W2886804753 cites W2079769693 @default.
• W2886804753 cites W2104700243 @default.
• W2886804753 cites W2120053891 @default.
• W2886804753 cites W2124882503 @default.
• W2886804753 cites W2139259380 @default.
• W2886804753 cites W2170592314 @default.
• W2886804753 cites W2193981223 @default.
• W2886804753 cites W2402327563 @default.
• W2886804753 cites W2412322771 @default.
• W2886804753 cites W2463613932 @default.
• W2886804753 cites W2465766882 @default.
• W2886804753 cites W2586818446 @default.
• W2886804753 cites W2588831318 @default.
• W2886804753 cites W2605215864 @default.
• W2886804753 cites W2614928609 @default.
• W2886804753 cites W2761252580 @default.
• W2886804753 cites W2762348989 @default.
• W2886804753 cites W348353939 @default.
• W2886804753 doi "https://doi.org/10.1097/aog.0000000000002777" @default.
• W2886804753 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6105436" @default.
• W2886804753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30095771" @default.
• W2886804753 hasPublicationYear "2018" @default.
• W2886804753 type Work @default.
• W2886804753 sameAs 2886804753 @default.
• W2886804753 citedByCount "27" @default.
• W2886804753 countsByYear W28868047532018 @default.
• W2886804753 countsByYear W28868047532019 @default.
• W2886804753 countsByYear W28868047532020 @default.
• W2886804753 countsByYear W28868047532021 @default.
• W2886804753 countsByYear W28868047532022 @default.
• W2886804753 countsByYear W28868047532023 @default.
• W2886804753 crossrefType "journal-article" @default.
• W2886804753 hasAuthorship W2886804753A5008356734 @default.
• W2886804753 hasAuthorship W2886804753A5023105695 @default.
• W2886804753 hasAuthorship W2886804753A5029198271 @default.
• W2886804753 hasAuthorship W2886804753A5042320425 @default.
• W2886804753 hasAuthorship W2886804753A5091136317 @default.
• W2886804753 hasBestOaLocation W28868047531 @default.
• W2886804753 hasConcept C118552586 @default.
• W2886804753 hasConcept C126322002 @default.
• W2886804753 hasConcept C136764020 @default.
• W2886804753 hasConcept C144024400 @default.
• W2886804753 hasConcept C149923435 @default.
• W2886804753 hasConcept C151956035 @default.
• W2886804753 hasConcept C156957248 @default.
• W2886804753 hasConcept C159110408 @default.
• W2886804753 hasConcept C160735492 @default.
• W2886804753 hasConcept C162324750 @default.
• W2886804753 hasConcept C2426938 @default.
• W2886804753 hasConcept C2776534028 @default.
• W2886804753 hasConcept C2778979077 @default.
• W2886804753 hasConcept C2779076696 @default.
• W2886804753 hasConcept C2781185258 @default.
• W2886804753 hasConcept C2908647359 @default.
• W2886804753 hasConcept C2986817661 @default.
• W2886804753 hasConcept C41008148 @default.
• W2886804753 hasConcept C50522688 @default.
• W2886804753 hasConcept C551499885 @default.
• W2886804753 hasConcept C71924100 @default.
• W2886804753 hasConcept C81603835 @default.
• W2886804753 hasConcept C99454951 @default.
• W2886804753 hasConceptScore W2886804753C118552586 @default.
• W2886804753 hasConceptScore W2886804753C126322002 @default.
• W2886804753 hasConceptScore W2886804753C136764020 @default.
• W2886804753 hasConceptScore W2886804753C144024400 @default.
• W2886804753 hasConceptScore W2886804753C149923435 @default.
• W2886804753 hasConceptScore W2886804753C151956035 @default.
• W2886804753 hasConceptScore W2886804753C156957248 @default.
• W2886804753 hasConceptScore W2886804753C159110408 @default.
• W2886804753 hasConceptScore W2886804753C160735492 @default.
• W2886804753 hasConceptScore W2886804753C162324750 @default.
• W2886804753 hasConceptScore W2886804753C2426938 @default.
• W2886804753 hasConceptScore W2886804753C2776534028 @default.
• W2886804753 hasConceptScore W2886804753C2778979077 @default.
• W2886804753 hasConceptScore W2886804753C2779076696 @default.
• W2886804753 hasConceptScore W2886804753C2781185258 @default.
• W2886804753 hasConceptScore W2886804753C2908647359 @default.
• W2886804753 hasConceptScore W2886804753C2986817661 @default.
• W2886804753 hasConceptScore W2886804753C41008148 @default.
• W2886804753 hasConceptScore W2886804753C50522688 @default.

• next